Publication dates

Oncology Industry, July 2014 Market Reports from Top Publishers

You might be interested in: molecular diagnostic, cancer, medical equipment, more »


 
1-10 of about 200 reports for Oncology

Oncology Partnering Terms and Agreements

Oncology Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • July 2014
  • by Currentpartnering

The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare ...

Optela AD (formerly known as Optela - Lazerni Technologii AD) (Bulgaria) - Company Profile

Optela AD (formerly known as Optela - Lazerni Technologii AD) (Bulgaria) - Company Profile

  • $ 64
  • Company report
  • July 2014
  • by SeeNews - Research & Profiles

Optela AD is a medium-range laser manufacturer in Eastern Europe, a producer of infra-red optics and the sole producer of laser therapy systems in Bulgaria. It also specialises in laser application and ...

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

... Immunotherapy in oncology drug pipeline update 2014 cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity ...

Angiogenesis in Oncology Drug Pipeline Update 2014

Angiogenesis in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 180 drugs. Angiogenesis in oncology drug pipeline update lists all drugs and gives you a progress analysis ...

Antibodies in Oncology Drug Pipeline Update 2014

Antibodies in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Antibodies in oncology drug pipeline update 2014 the commercial and therapeutic success of antibodies like rituxan, avastin, and erbitux will force the industry to look into the next generation ...

Apoptosis in Oncology Drug Pipeline Update 2014

Apoptosis in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... In addition, there are 10 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 216 drugs. Apoptosis in oncology drug pipeline update lists all drugs and gives you ...

Cellular Therapy in Oncology Drug Pipeline Update 2014

Cellular Therapy in Oncology Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

... There are 6 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 64 drugs. Cellular therapy in oncology drug pipeline update lists all drugs and gives you a progress ...

Cytokine Therapy in Oncology Drug Pipeline Update 2014

Cytokine Therapy in Oncology Drug Pipeline Update 2014

  • $ 1 499
  • Industry report
  • July 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 8 drugs. Cytokine therapy in oncology drug pipeline update lists all drugs and gives you a progress analysis ...

Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 97 drugs. Gene therapy in oncology drug pipeline update lists all drugs and gives you a progress analysis ...

Peptides in Oncology Drug Pipeline Update 2014

Peptides in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Drugs and the accumulated number of ceased drugs over the last years amount to another 129 drugs. Peptides in oncology drug pipeline update lists all drugs and gives you a progress analysis on each one ...

About 5 600 reports for Oncology

Download Unlimited Documents from Trusted Public Sources

The future of the Oncology Industry in the US

  • Maximizing Value in a Changing Paradigm
  • January 2012
    16 pages
  • Oncology  

  • United States  

    Europe  

    World  

View report >

4 Companies for Oncology

Read our Company Profiles

Primary Sources

United States

Abbott Laboratories

United States

Eli Lilly and Co.

United States

Roche Diagnostics

South Africa

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.